About Inamed CRO
Inamed CRO is a company based in Gauting (Germany) founded in 1998 was acquired by NUVISAN in January 2020. The company has 432 employees as of December 31, 2021. Inamed CRO offers products and services including Omics & Biomarkers Services, Clinical Trial Services, CMC Services, and Digital Science Services. Inamed CRO operates in a competitive market with competitors including Celgene, Syneos Health, Medelis WCCT Global, Parexel and Emmes, among others.
- Headquarter Gauting, Germany
- Employees 432 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nuvisan Gmbh
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Inamed CRO
Inamed CRO offers a comprehensive portfolio of products and services, including Omics & Biomarkers Services, Clinical Trial Services, CMC Services, and Digital Science Services.
Analytical tools for biomarkers in drug discovery processes
Conducts phase 1 and 2 trials with bioanalysis support
Develops drug substances and products for trials
Applies ML and bioinformatics for drug development
Funding Insights of Inamed CRO
Detailed funding history for Inamed CRO
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Inamed CRO
Inamed CRO has secured backing from 1 investor. Prominent investors backing the company include NUVISAN.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Clinical trial supply and bioanalytical services are provided globally.
|
Locked | Locked | Locked |
Investor details for Inamed CRO
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Inamed CRO
Investment portfolio details for Inamed CRO
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Inamed CRO
Detailed financials for Inamed CRO
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Inamed Cro Comparisons
Peer comparison for Inamed CRO
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Inamed CRO
Inamed CRO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Medelis WCCT Global, Parexel and Emmes, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
Detailed competitors of Inamed CRO
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inamed Cro
Complete news archive for Inamed CRO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inamed CRO
Inamed CRO was founded in 1998.
Inamed CRO is headquartered in Gauting, Germany. It is registered at Gauting, Bavaria, Germany.
As of Dec 31, 2021, the latest employee count at Inamed CRO is 432.
Founded in 1998 in Gauting, Germany, Inamed functions as a contract research organization in the pharmaceutical sector. Operations are structured into two divisions: Inamed Respiratory, where clinical trials from preclinical to Phase IV are conducted for respiratory-targeted drugs, encompassing in-vitro studies, lung deposition assessments, biostatistics, data management, and medical writing; and Inamed Phase I, where early-stage services such as first-in-human trials, pharmacokinetic evaluations, proof-of-concept studies, and patient recruitment are managed.
Inamed CRO's top competitors include Emmes, Syneos Health and ClinChoice.
Inamed CRO offers Omics & Biomarkers Services, Clinical Trial Services, CMC Services, and Digital Science Services.
Inamed CRO has 1 investor. Key investors include NUVISAN.